Exela Pharma recalls 400K drugs

Exela Pharma Sciences, an injectable drug company, is recalling more than 415,000 drug vials in a Class I recall because of a possible presence of silicone, according to the FDA. 

The recall includes about 355,000 8.4% sodium bicarbonate injection vials, 23,000 midazolam in 0.8% sodium chloride injection vials, and 38,000 cysteine hydrochloride injection vials. 

Exela and Civica alerted customers of the issue in late October. 

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars